Galactose

Jump to: navigation, search
Template:Chembox E number
Galactose
Identifiers
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
MeSH Galactose
Properties
C6H12O6
Molar mass 180.08
Melting point
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

WikiDoc Resources for Galactose

Articles

Most recent articles on Galactose

Most cited articles on Galactose

Review articles on Galactose

Articles on Galactose in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Galactose

Images of Galactose

Photos of Galactose

Podcasts & MP3s on Galactose

Videos on Galactose

Evidence Based Medicine

Cochrane Collaboration on Galactose

Bandolier on Galactose

TRIP on Galactose

Clinical Trials

Ongoing Trials on Galactose at Clinical Trials.gov

Trial results on Galactose

Clinical Trials on Galactose at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Galactose

NICE Guidance on Galactose

NHS PRODIGY Guidance

FDA on Galactose

CDC on Galactose

Books

Books on Galactose

News

Galactose in the news

Be alerted to news on Galactose

News trends on Galactose

Commentary

Blogs on Galactose

Definitions

Definitions of Galactose

Patient Resources / Community

Patient resources on Galactose

Discussion groups on Galactose

Patient Handouts on Galactose

Directions to Hospitals Treating Galactose

Risk calculators and risk factors for Galactose

Healthcare Provider Resources

Symptoms of Galactose

Causes & Risk Factors for Galactose

Diagnostic studies for Galactose

Treatment of Galactose

Continuing Medical Education (CME)

CME Programs on Galactose

International

Galactose en Espanol

Galactose en Francais

Business

Galactose in the Marketplace

Patents on Galactose

Experimental / Informatics

List of terms related to Galactose

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Galactose (Gal) (also called brain sugar[1]) is a type of sugar which is less sweet than glucose and not very water-soluble. It is considered a nutritive sweetener because it has food energy.

Galactan is a polymer of the sugar galactose. It is found in hemicellulose and can be converted to galactose by hydrolysis.

Sources

It is found in dairy products, in sugar beets and other gums and mucilages.

It is also synthesized by the body, where it forms part of glycolipids and glycoproteins in several tissues.

Relationship to lactose

Galactose is a monosaccharide constituent, together with glucose, of the disaccharide lactose. The hydrolysis of lactose to glucose and galactose is catalyzed by the enzyme lactase, a β-galactosidase. In the human body, glucose is changed into galactose in order to enable the mammary glands to secrete lactose.

Galactose and glucose are produced by hydrolysis of lactose by β-galactosidase. This enzyme is produced by the lac operon in Escherichia coli (E. coli).

Clinical significance

Two studies have suggested a possible link between galactose in milk and ovarian cancer.[2][3] Other studies show no correlation, even in the presence of defective galactose metabolism.[4][5] More recently, pooled analysis done by the Harvard School of Public Health showed no specific correlation between lactose containing foods and ovarian cancer, and showed statistically insignificant increases in risk for consumption of lactose at ≥30 g/d.[6] More research is necessary to ascertain possible risks.

There are some ongoing studies which suggest that galactose may have a role in treatment of focal segmental glomerulosclerosis (a kidney disease resulting in kidney failure and proteinuria). This effect is likely to be a result of binding of galactose to FSGS factor.

Structure and isomerism

The first and last -OH groups point the same way and the second and third -OH groups point the other way. D-Galactose has the same configuration at its penultimate carbon as D-glyceraldehyde. Galactose is a diastereomer of glucose.

Liver galactose metabolism

In the liver, galactose is converted to glucose 1-phosphate. Glucose 1-phosphate is later on converted to glucose 6-phosphate by the action of the enzyme phosphoglucomutase. Shown below is a diagram depicting galactose metabolism and the different enzymes involved in it.


Galactose metabolism.png

Metabolic disorders

There are 3 important disorders involving galactose depending on the type of deficient enzyme:

Name Enzyme Description
Galactosemia Galactokinase Causes cataracts and mental retardation. If a galactose-free diet starts sufficiently early, the cataracts will regress without complications however neurological damage is permanent.
UDPgalactose-4-epimerase deficiency UDPgalactose-4-epimerase Is extremely rare (only 2 reported cases). It causes nerve deafness.
Galactose-1-phosphate uridyl transferase deficiency Galactose-1-phosphate uridyl transferase Is the most problematic, as galactose-free diets do not have considerable long-term effects.

References

  1. Compact American Medical Dictionary. Houghton Mifflin Reference Books (1998). ISBN 0395884098
  2. Cramer D (1989). "Lactase persistence and milk consumption as determinants of ovarian cancer risk". Am J Epidemiol. 130 (5): 904–10. PMID 2510499.
  3. Cramer D, Harlow B, Willett W, Welch W, Bell D, Scully R, Ng W, Knapp R (1989). "Galactose consumption and metabolism in relation to the risk of ovarian cancer". Lancet. 2 (8654): 66–71. PMID 2567871.
  4. Marc T. Goodman , Anna H. Wu , Ko-Hui Tung , Katharine McDuffie , Daniel W. Cramer , Lynne R. Wilkens , Keith Terada , Juergen K. V. Reichardt , and Won G. Ng (2002). "Association of Galactose-1-Phosphate Uridyltransferase Activity and N314D Genotype with the Risk of Ovarian Cancer". Am. J. Epidemiol. 156 (8): 693–701. PMID 12370157.
  5. Fung, W. L. Alan, Risch, Harvey, McLaughlin, John, Rosen, Barry, Cole, David, Vesprini, Danny, Narod, Steven A. (2003). "The N314D Polymorphism of Galactose-1-Phosphate Uridyl Transferase Does Not Modify the Risk of Ovarian Cancer". Cancer Epidemiol Biomarkers Prev. 12 (7): 678–80. PMID 12869412.
  6. Genkinger, Jeanine M., Hunter, David J., Spiegelman, Donna, Anderson, Kristin E., Arslan, Alan, Beeson, W. Lawrence, Buring, Julie E., Fraser, Gary E., Freudenheim, Jo L., Goldbohm, R. Alexandra, Hankinson, Susan E., Jacobs, David R., Jr., Koushik, Anita, Lacey, James V., Jr., Larsson, Susanna C., Leitzmann, Michael, McCullough, Marji L., Miller, Anthony B., Rodriguez, Carmen, Rohan, Thomas E., Schouten, Leo J., Shore, Roy, Smit, Ellen, Wolk, Alicja, Zhang, Shumin M., Smith-Warner, Stephanie A. (2006). "Dairy Products and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies". Cancer Epidemiol Biomarkers Prev. 15: 364–372. PMID 16492930.


ar:جالكتوز ca:Galactosa da:Galaktose de:Galaktose it:Galattosio he:גלקטוז la:Galactosium ms:Galaktosa nl:Galactose no:Galaktose sr:Галактоза sh:Galaktoza fi:Galaktoosi sv:Galaktos th:กาแล็กโทส



Linked-in.jpg